Search results
Results from the WOW.Com Content Network
The new study highlights the need for continued research on the subject, especially as daily marijuana use grows in popularity, Hanna said. Despite the study’s limitations, “it still suggests ...
PHEC-66 is an extract of cannabis which, in at least one study published in the peer reviewed journal Cells, has been found to be an effective treatment for melanoma, [1] [2] by triggering cell apoptosis. [3]
Research on the medical benefits of cannabis has been hindered by various federal regulations, including its Schedule I classification. [3] To conduct research on cannabis, approval must be obtained from the Food and Drug Administration, [4] and a license must be obtained from the Drug Enforcement Administration specific to Schedule I drugs. [5]
Using marijuana daily for years may raise the overall risk of head and neck cancers three- to five-fold, according to a new study that analyzed millions of medical records. “Our research shows ...
The American Cancer Society [154] and American Psychological Association [155] have noted the obstacles that exist for conducting research on cannabis, and have called on the federal government to better enable scientific study of the drug. Cancer Research UK say that while cannabis is being studied for therapeutic potential, "claims that there ...
Cannabis smoke was listed as a cancer agent in California in 2009. [31] A study by the British Lung Foundation published in 2012 identifies cannabis smoke as a carcinogen and also finds awareness of the danger is low compared with the high awareness of the dangers of smoking tobacco particularly among younger users. Other observations include ...
Cannabis and Cannabinoid Research is a quarterly peer-reviewed academic journal published by Mary Ann Liebert since 2016 and "dedicated to the scientific, medical, and psychosocial exploration of clinical cannabis, cannabinoids, and the biochemical mechanisms of endocannabinoids".
From 2008 to 2012, the American Patients Rights Association, in cooperation with Medical Marijuana expert Kim Quiggle, lobbied the federal government over what is now known as the "Mary Lou Eimer Criteria" based on a medical study performed by Quiggle on over 10,000 chronically ill and terminally ill patients' use of medical marijuana in ...